Catch up with our ASCO 2015 analysis and insights with our white paper, roundtable recordings and market leading report. To compete successfully in this market you’ll need our trusted analysis.
Contact Us If you want to know more about what analysis we have in the oncology space, or would like to talk to someone about this, simple request a call back to learn more...
With ASCO over for another year we’ve put together an overview of key highlights from this year’s conference.
Our NEW white paper allows you to read through the results and implications of these key abstracts, chosen by our expert analysts, allowing you and your business to evolve with the oncology market.
The striking results being achieved by immuno-oncology treatments have sparked a huge interest in this field. The intense interest in the field of immuno-oncology has been fueled by the prospect of significantly improving survival in cancer patients and by high prices that can be charged for immuno-oncology drugs.
You can get to grips with this exciting and promising treatment trend in the oncology space with our brand new immuno-oncology overview report. We’ve worked with analysts on BioMedTracker to give you a detailed look at this market and help you understand where it’s heading, giving you a competitive edge.
Informa put together a roundtable of industry experts across products such as Datamonitor Healthcare, The Pink Sheet, Citeline and BioMedTracker. They covered what to watch out for at the event and their predicted implications of these results.
You can now watch this much anticipated and exciting event for free by clicking on the button below.
The session is hosted by Mary Jo Laffler, Bureau Chief, Clinical Development and Business Coverage for industry leading publication ‘The Pink Sheet’. She was joined by:
> Joseph Hedden, Senior Analyst in Oncology for Datamonitor Healthcare
> Daphna Halpern, Oncology Director for Citeline, and
> Robert Jeng, Senior Scientific Analyst for BioMedTracker.
After the conference another team of industry experts came together to analyse the key highlights from the conference, assess its winners and losers and examine the implications for the future of the oncology treatment landscape.
The session was again hosted by Mary Jo Laffler, Bureau Chief, Clinical Development and Business Coverage for industry leading publication ‘The Pink Sheet’. She was joined by:
– Joseph Hedden, Senior Analyst in Oncology for Datamonitor Healthcare
– Rachel Meighan-Mantha, Principal Analyst in Oncology for Citeline
– Edny Inui, Senior Scientific Analyst for BioMedTracker and Product Manager for KOL Insight, and
– Robert Jeng, Senior Scientific Analyst for BioMedTracker
Datamonitor Healthcare is proud to be a part of Informa’s “Future of Oncology” community. Here you will find all content across the Informa products about ASCO 2015, key insights, analysis and stories.
On this micro site you’ll find analysis and insight from a vast range of products covering all aspects of the oncology market. This site is a valuable tool for anyone who wishes to be successful in the oncology market.
Request your FREE demo here We're more than just oncology analysis... At Datamonitor Healthcare we provide details and accurate analysis on a range of different disease indications, company types and hot topics. If you'd like to know about how we can add value to your business and put you one step ahead of your competitors just request your free demo below...
You now have full access to all articles on our site for the next 28 days.